Reviewing United Treatment Centers (OTCMKTS:POTN) & Strata Skin Sciences (NASDAQ:SSKN)

Strata Skin Sciences (NASDAQ:SSKN) and United Treatment Centers (OTCMKTS:POTN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends.

Valuation and Earnings

This table compares Strata Skin Sciences and United Treatment Centers”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$33.56 million	0.22	-$10.09 million	($2.84)	-0.63
United Treatment Centers	N/A	N/A	N/A	N/A	N/A

United Treatment Centers has lower revenue, but higher earnings than Strata Skin Sciences.

Analyst Ratings

This is a summary of current recommendations and price targets for Strata Skin Sciences and United Treatment Centers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	0	0	1	0	3.00
United Treatment Centers	0	0	0	0	0.00

Strata Skin Sciences currently has a consensus target price of $6.00, suggesting a potential upside of 235.20%. Given Strata Skin Sciences’ stronger consensus rating and higher probable upside, equities analysts clearly believe Strata Skin Sciences is more favorable than United Treatment Centers.

Insider & Institutional Ownership

32.4% of Strata Skin Sciences shares are owned by institutional investors. 39.0% of Strata Skin Sciences shares are owned by insiders. Comparatively, 0.2% of United Treatment Centers shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Strata Skin Sciences and United Treatment Centers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.13%	-203.84%	-31.30%
United Treatment Centers	N/A	N/A	N/A

Summary

Strata Skin Sciences beats United Treatment Centers on 6 of the 9 factors compared between the two stocks.

About Strata Skin Sciences

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

About United Treatment Centers

Diamond Wellness Holdings Inc., through its subsidiaries, engages in the development and sale of hemp-derived cannabidiol (CBD) oil products. It offers flavored and unflavored oils; vaping pens and additives; edibles, such as chewable gummies and lollipops; capsules; beverage energy/relaxation shots; topical application creams in various concentrations; dog and cat wellness products in various dosages and delivery formats; skin care, bath, and body products; and hemp flowers. The company provides its products under various brands, including Diamond CBD, Chill, Relax, MediPets, and Meds BioTech, as well as various other brands. It sells its products through distributors and resellers, as well as through its Website. The company was formerly known as PotNetwork Holdings, Inc. Diamond Wellness Holdings Inc. is based in Fort Lauderdale, Florida.